科学文献
我们与学术机构开展合作研究，以评估我们的管线产品。以下是发表的相关文献。
Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma
TG Martin, D Madduri, L Pacaud, SZ Usmani
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
J. San‑Miguel, B. Dhakal, K. Yong, A. Spencer, S. Anguille, M.-V. Mateos, C. Fernández de Larrea, J. Martínez‑López, P. Moreau, C. Touzeau, X. Leleu, I. Avivi, M. Cavo, T. Ishida, S.J. Kim, W. Roeloffzen, N.W.C.J. van de Donk, D. Dytfeld, S. Sidana, L.J. Costa, A. Oriol, R. Popat, A.M. Khan, Y.C. Cohen, P.J. Ho, J. Griffin, N. Lendvai, C. Lonardi, A. Slaughter, J.M. Schecter, C.C. Jackson, K. Connors, K. Li, E. Zudaire, D. Chen, J. Gilbert, T. Yeh, S. Nagle, E. Florendo, L. Pacaud, N. Patel, S.J. Harrison, and H. Einsele
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma
S Palmer, Y Lin, TG Martin, S Jagannath, A Jakubowiak, SZ Usmani, N Buyukkaramikli, H Phelps, R Slowik, F Pan, S Valluri, L Pacaud, G Jackson
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C. Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D. Cohen
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C. Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D. Cohen
